Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers

作者: Jiayun Shen , Henry Lik-Yuen Chan , Grace Lai-Hung Wong , Paul Cheung-Lung Choi , Anthony Wing-Hung Chan

DOI: 10.1016/J.JHEP.2011.12.025

关键词: Nonalcoholic fatty liver diseaseLiver biopsyBiologyFatty acid-binding proteinGastroenterologyEndocrinologyFatty liverSteatohepatitisFGF21Internal medicineBody mass indexBiomarker (medicine)

摘要: Background & Aims The diagnosis of non-alcoholic fatty liver disease (NAFLD) and steatohepatitis (NASH) is limited by the need for biopsy. We aimed at testing accuracy cytokeratin-18 fragment (CK-18), adipocyte acid binding protein (AFABP) fibroblast growth factor 21 (FGF21) NAFLD NASH. Methods 146 patients with biopsy-proven 74 age- gender-matched healthy controls were included. Serum CK-18, AFABP FGF21 levels determined enzyme-linked immunosorbent assay. Results AFABP, increased in a stepwise fashion control subjects (median 103U/L, 15.4ng/ml, 104pg/ml), non-NASH (263U/L, 18.9ng/ml, 249pg/ml) NASH (418U/L, 19.4ng/ml, 354pg/ml) ( p Conclusions CK-18 most accurate biomarker A two-step approach using further improves diagnosing

参考文章(30)
Michael Charlton, Paul Angulo, Naga Chalasani, Ralph Merriman, Kimberly Viker, Phunchai Charatcharoenwitthaya, Schuyler Sanderson, Samer Gawrieh, Anuradha Krishnan, Keith Lindor, Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease Hepatology. ,vol. 47, pp. 484- 492 ,(2007) , 10.1002/HEP.22063
Naim Alkhouri, Rocio Lopez, Michael Berk, Ariel E. Feldstein, Serum retinol-binding protein 4 levels in patients with nonalcoholic fatty liver disease. Journal of Clinical Gastroenterology. ,vol. 43, pp. 985- 989 ,(2009) , 10.1097/MCG.0B013E3181A0998D
Mattias Ekstedt, Lennart E. Franzén, Ulrik L. Mathiesen, Lars Thorelius, Marika Holmqvist, Göran Bodemar, Stergios Kechagias, Long-term follow-up of patients with NAFLD and elevated liver enzymes Hepatology. ,vol. 44, pp. 865- 873 ,(2006) , 10.1002/HEP.21327
Youming Li, Chengfu Xu, Chaohui Yu, Lei Xu, Min Miao, Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. Journal of Hepatology. ,vol. 50, pp. 1029- 1034 ,(2009) , 10.1016/J.JHEP.2008.11.021
C MATTEONI, Z YOUNOSSI, T GRAMLICH, N BOPARAI, Y LIU, A MCCULLOUGH, Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. ,vol. 116, pp. 1413- 1419 ,(1999) , 10.1016/S0016-5085(99)70506-8
Masahiko Shimada, Hiromu Kawahara, Kazuaki Ozaki, Masayuki Fukura, Hirokazu Yano, Mutsumi Tsuchishima, Mikihiro Tsutsumi, Shujiro Takase, Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis. The American Journal of Gastroenterology. ,vol. 102, pp. 1931- 1938 ,(2007) , 10.1111/J.1572-0241.2007.01322.X
Leon A. Adams, James F. Lymp, Jenny St. Sauver, Schuyler O. Sanderson, Keith D. Lindor, Ariel Feldstein, Paul Angulo, The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study Gastroenterology. ,vol. 129, pp. 113- 121 ,(2005) , 10.1053/J.GASTRO.2005.04.014
Lauren N. Bell, Janice L. Theodorakis, Raj Vuppalanchi, Romil Saxena, Kerry G. Bemis, Mu Wang, Naga Chalasani, Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease Hepatology. ,vol. 51, pp. 111- 120 ,(2010) , 10.1002/HEP.23271
Jody Dushay, Patricia C. Chui, Gosala S. Gopalakrishnan, Marta Varela–Rey, Meghan Crawley, Ffolliott M. Fisher, Michael K. Badman, Maria L. Martinez–Chantar, Eleftheria Maratos–Flier, Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease Gastroenterology. ,vol. 139, pp. 456- 463 ,(2010) , 10.1053/J.GASTRO.2010.04.054
Rafeeq Ali, Kenneth Cusi, None, New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD). Annals of Medicine. ,vol. 41, pp. 265- 278 ,(2009) , 10.1080/07853890802552437